310 related articles for article (PubMed ID: 12433678)
1. CD40 induces human multiple myeloma cell migration via phosphatidylinositol 3-kinase/AKT/NF-kappa B signaling.
Tai YT; Podar K; Mitsiades N; Lin B; Mitsiades C; Gupta D; Akiyama M; Catley L; Hideshima T; Munshi NC; Treon SP; Anderson KC
Blood; 2003 Apr; 101(7):2762-9. PubMed ID: 12433678
[TBL] [Abstract][Full Text] [Related]
2. Osteopontin stimulates cell motility and nuclear factor kappaB-mediated secretion of urokinase type plasminogen activator through phosphatidylinositol 3-kinase/Akt signaling pathways in breast cancer cells.
Das R; Mahabeleshwar GH; Kundu GC
J Biol Chem; 2003 Aug; 278(31):28593-606. PubMed ID: 12771144
[TBL] [Abstract][Full Text] [Related]
3. Phosphatidylinositol 3-kinase and NF-kappa B/Rel are at the divergence of CD40-mediated proliferation and survival pathways.
Andjelic S; Hsia C; Suzuki H; Kadowaki T; Koyasu S; Liou HC
J Immunol; 2000 Oct; 165(7):3860-7. PubMed ID: 11034392
[TBL] [Abstract][Full Text] [Related]
4. Osteopontin: it's role in regulation of cell motility and nuclear factor kappa B-mediated urokinase type plasminogen activator expression.
Das R; Philip S; Mahabeleshwar GH; Bulbule A; Kundu GC
IUBMB Life; 2005 Jun; 57(6):441-7. PubMed ID: 16012053
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor-1 induces adhesion and migration in human multiple myeloma cells via activation of beta1-integrin and phosphatidylinositol 3'-kinase/AKT signaling.
Tai YT; Podar K; Catley L; Tseng YH; Akiyama M; Shringarpure R; Burger R; Hideshima T; Chauhan D; Mitsiades N; Richardson P; Munshi NC; Kahn CR; Mitsiades C; Anderson KC
Cancer Res; 2003 Sep; 63(18):5850-8. PubMed ID: 14522909
[TBL] [Abstract][Full Text] [Related]
6. B cell receptor (BCR) cross-talk: CD40 engagement creates an alternate pathway for BCR signaling that activates I kappa B kinase/I kappa B alpha/NF-kappa B without the need for PI3K and phospholipase C gamma.
Mizuno T; Rothstein TL
J Immunol; 2005 May; 174(10):6062-70. PubMed ID: 15879100
[TBL] [Abstract][Full Text] [Related]
7. Downstream effectors of oncogenic ras in multiple myeloma cells.
Hu L; Shi Y; Hsu JH; Gera J; Van Ness B; Lichtenstein A
Blood; 2003 Apr; 101(8):3126-35. PubMed ID: 12515720
[TBL] [Abstract][Full Text] [Related]
8. Pyrrolidine dithiocarbamate-induced neuronal cell death is mediated by Akt, casein kinase 2, c-Jun N-terminal kinase, and IkappaB kinase in embryonic hippocampal progenitor cells.
Min YK; Park JH; Chong SA; Kim YS; Ahn YS; Seo JT; Bae YS; Chung KC
J Neurosci Res; 2003 Mar; 71(5):689-700. PubMed ID: 12584727
[TBL] [Abstract][Full Text] [Related]
9. CXCL16 signals via Gi, phosphatidylinositol 3-kinase, Akt, I kappa B kinase, and nuclear factor-kappa B and induces cell-cell adhesion and aortic smooth muscle cell proliferation.
Chandrasekar B; Bysani S; Mummidi S
J Biol Chem; 2004 Jan; 279(5):3188-96. PubMed ID: 14625285
[TBL] [Abstract][Full Text] [Related]
10. CD40 activates NF-kappa B and c-Jun N-terminal kinase and enhances chemokine secretion on activated human hepatic stellate cells.
Schwabe RF; Schnabl B; Kweon YO; Brenner DA
J Immunol; 2001 Jun; 166(11):6812-9. PubMed ID: 11359840
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms by which SGN-40, a humanized anti-CD40 antibody, induces cytotoxicity in human multiple myeloma cells: clinical implications.
Tai YT; Catley LP; Mitsiades CS; Burger R; Podar K; Shringpaure R; Hideshima T; Chauhan D; Hamasaki M; Ishitsuka K; Richardson P; Treon SP; Munshi NC; Anderson KC
Cancer Res; 2004 Apr; 64(8):2846-52. PubMed ID: 15087402
[TBL] [Abstract][Full Text] [Related]
12. Lysyl oxidase inhibits ras-mediated transformation by preventing activation of NF-kappa B.
Jeay S; Pianetti S; Kagan HM; Sonenshein GE
Mol Cell Biol; 2003 Apr; 23(7):2251-63. PubMed ID: 12640111
[TBL] [Abstract][Full Text] [Related]
13. Biologic sequelae of interleukin-6 induced PI3-K/Akt signaling in multiple myeloma.
Hideshima T; Nakamura N; Chauhan D; Anderson KC
Oncogene; 2001 Sep; 20(42):5991-6000. PubMed ID: 11593406
[TBL] [Abstract][Full Text] [Related]
14. Requirement of phosphoinositide 3-kinase and Akt for interferon-beta-mediated induction of the beta-R1 (SCYB11) gene.
Rani MR; Hibbert L; Sizemore N; Stark GR; Ransohoff RM
J Biol Chem; 2002 Oct; 277(41):38456-61. PubMed ID: 12169689
[TBL] [Abstract][Full Text] [Related]
15. Heparin-binding epidermal growth factor-like growth factor inhibits cytokine-induced NF-kappa B activation and nitric oxide production via activation of the phosphatidylinositol 3-kinase pathway.
Mehta VB; Besner GE
J Immunol; 2005 Aug; 175(3):1911-8. PubMed ID: 16034135
[TBL] [Abstract][Full Text] [Related]
16. PYK2 links G(q)alpha and G(13)alpha signaling to NF-kappa B activation.
Shi CS; Kehrl JH
J Biol Chem; 2001 Aug; 276(34):31845-50. PubMed ID: 11435419
[TBL] [Abstract][Full Text] [Related]
17. D(4) dopamine receptor differentially regulates Akt/nuclear factor-kappa b and extracellular signal-regulated kinase pathways in D(4)MN9D cells.
Zhen X; Zhang J; Johnson GP; Friedman E
Mol Pharmacol; 2001 Oct; 60(4):857-64. PubMed ID: 11562449
[TBL] [Abstract][Full Text] [Related]
18. Role of the phosphatidylinositol 3 kinase-Akt pathway in the regulation of IL-10 and IL-12 by Porphyromonas gingivalis lipopolysaccharide.
Martin M; Schifferle RE; Cuesta N; Vogel SN; Katz J; Michalek SM
J Immunol; 2003 Jul; 171(2):717-25. PubMed ID: 12847238
[TBL] [Abstract][Full Text] [Related]
19. Human anti-CD40 antagonist antibody triggers significant antitumor activity against human multiple myeloma.
Tai YT; Li X; Tong X; Santos D; Otsuki T; Catley L; Tournilhac O; Podar K; Hideshima T; Schlossman R; Richardson P; Munshi NC; Luqman M; Anderson KC
Cancer Res; 2005 Jul; 65(13):5898-906. PubMed ID: 15994968
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotection by transforming growth factor-beta1 involves activation of nuclear factor-kappaB through phosphatidylinositol-3-OH kinase/Akt and mitogen-activated protein kinase-extracellular-signal regulated kinase1,2 signaling pathways.
Zhu Y; Culmsee C; Klumpp S; Krieglstein J
Neuroscience; 2004; 123(4):897-906. PubMed ID: 14751283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
